Clostridium difficile associated disease – dramatic increase in the incidence among hospitalized patients

Authors

  • Lurdes Correia Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra – EPE
  • Rita Monteiro Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra – EPE
  • Tiago Alfaro Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra – EPE
  • Adélia Simão Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra – EPE
  • Armando Carvalho Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra – EPE
  • Nascimento Costa Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra – EPE

Keywords:

Clostridium difficile, pseudomembranous colitis, nosocomial diarrhoea, vancomycin, metronidazole

Abstract

Many publications show an incidence increase of Clostridium
difficile (CD) associated disease (CDAD), affecting both in- and
outpatients being these recent infections more severe and difficult
to treat. The aim of this retrospective study is to evaluate the
incidence and clinical impact of CDAD in patients hospitalized
from the 1st January 2004 to the 31st December 2009. Suggestive clinical manifestations and at least one of the following
were the inclusion criteria: CDAD compatible colonoscopy or CD
positive toxin. We identified 83 cases of CDAD (32M, 51W), in a
total of 9581 patients (5198M, 4383W). Age ranging from 47 to
94 years (average 79). Five patients had CDAD acquired in the
community and 78 in hospital environment. The incidence of CDAD
increased almost six fold between 2004 and 2009 (4.35/1000 vs.
21.63/1000), and 77.11% developed the disease during hospitalization. The disease was more frequent in women (11.64/1000
vs. 6.16/1000). All patients had undergone prior antibiotherapy.
The comorbidities, number of antibiotics used, advanced age,
duration of the antibiotherapy and the length of hospitalization
did not seem to justify the increase in incidence and severity. In
96% the diagnosis was confirmed by the presence of Clostridium
toxin and in 4% by colonoscopy. Seventy three patients (88%)
were treated with metronidazole and 30% died (the department
overall mortality was 13%). Probably, it was the advanced age
related with the worst severity scenario which caused the high
mortality in our cases.

Downloads

Download data is not yet available.

References

Goldman LEE, Ausiello Dennis. Cecil Medicine 23ª Edição. Rio de Janeiro: Elsevier.2009:2536-2538.

Cohen SH, Gerding DN, Johnson S et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA), Infect Control Hosp Epidemiol 2010; 31:431-455.

Bartlett, JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease, Ann Intern Med 2006; 145:758.

Kelly CP, LaMont T. Clostridium difficile – more difficult than ever. N Engl J Med 2008;359:1932-1940.

Filipe S. Infecção no Hospital. Medicina e Saúde 2007; 120:20-22.

Vieira AM, Machado MV, Lito L et al.Diarreia associada a Clostridium difficile num hospital central. GE-J Port Gastrenterol 2010; 17:10-17.

Voth DE, Ballard JD.C.difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005;18:247-263.

LaMont JT, Calderwood SB, Baron EL. Epidemiology, microbiology, and pathophysiology of Clostridium difficile infection. UpTodate 2009.

Barbut F, Gariazzo B, Bonne L et al. Clinical features of C.difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol 2007;28:131-139.

Barbut F, Delmee M, Brazier JS et al. A European survey of diagnostic methods and testing protocols for C. difficile. Clin Microbiol Infect 2003;9:989-996.

Olson MM, Shanholtzer CJ, Lee JT et al. Ten years of prospective Clostridium difficile-associated disease surveillance and treatmenrat the

Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 1994;15:371-381.

Surawicz CM. Antibiotics and C.difficile: cause and cure. J Clin Gastroenterol 2007; 41:1-2.

Lynne, V. Renewed interest in a difficult disease: Costridium difficile infections –epidemiology and current treatment strategies. Curr Opin Gastroenterol.2009;25(1):24-35.

Bettin K, Clabots C, Mathie P et al. Effectiveness of liquid soap vs. chlorhexidine gluconate for the removal of Clostridium difficile from bare hands and gloved hands. Infect Control Hosp Epidemiol 1994; 15:697.

Boyce, JM, Pittet, D, Healthcare Infection Control Practices Advisory Committee, HICPAC/SHEA/APIC/IDSA Hand Hygiene Task, Force. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep 2002; 51:1.

Jabbar U, Leischner J, Kasper D et al. Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol 2010; 31:565.

Oughton MT, Loo VG, Dendukuri N et al. Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol 2009; 30:939

Additional Files

Published

2012-06-29

How to Cite

1.
Correia L, Monteiro R, Alfaro T, Simão A, Carvalho A, Costa N. Clostridium difficile associated disease – dramatic increase in the incidence among hospitalized patients. RPMI [Internet]. 2012 Jun. 29 [cited 2024 Dec. 18];19(2):61-8. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1141

Issue

Section

Original Articles

Most read articles by the same author(s)

1 2 > >>